Literature DB >> 33958720

LncRNA PINK1-AS promotes Gαi1-driven gastric cancer tumorigenesis by sponging microRNA-200a.

Yan Lv1, Yin Wang2, Yu Song3, Shu-Sheng Wang4, Kai-Wen Cheng2, Zhi-Qing Zhang2, Jin Yao5, Li-Na Zhou6, Zhuo-Yan Ling7, Cong Cao8,9,10.   

Abstract

Gastric cancer (GC) is one of the leading causes of human mortality around the world. We have previously shown that Gαi1 (the inhibitory subunit 1 of the heterotrimeric guanine nucleotide-binding protein) recruitment to ligand-activated receptor tyrosine kinases (RTKs) is essential for signaling. Testing its role in GC cancer-promoting functions, we found that Gαi1 is upregulated in human GC, correlating with poor overall survival. In established and primary human GC cells, Gαi1 shRNA (small hairpin RNA) or knockout produced significant anti-GC cell activity, proliferation and migration was inhibited, and apoptosis was activated. Conversely, ectopic Gαi1 overexpression promoted proliferation and migration of GC cells in vitro. By examining the tumor-suppressive miRNA microRNA-200a (miR-200a), we found that miR-200a directly silenced Gαi1 to induce anti-GC cell activity. The expression of miR-200a was downregulated in human GC, correlating with upregulation of a novel miR-200a-targeting long non-coding RNA (LncRNA), PINK1 (PTEN Induced Kinase 1)-AS. RNA immunoprecipitation, RNA-pull down, and RNA fluorescence in situ hybridization assays confirmed that PINK1-AS directly binds to miR-200a. Silencing PINK1-AS in GC cells led to miR-200a accumulation, Gαi1 downregulation, and inhibition of GC cell progression in vitro, whereas PINK1-AS upregulation produced the converse results. Significantly, anti-GC cell activity induced by PINK1-AS shRNA was ameliorated by the expression of miR-200a antisense or the 3'-UTR (untranslated region)-depleted Gαi1. In vivo, the growth of subcutaneous MGC-803 xenografts in nude mice was inhibited by PINK1-AS shRNA, but accelerated by PINK1-AS overexpression. Patient-derived GC xenograft growth in nude mice was largely inhibited after intratumoral injection of PINK1-AS shRNA lentivirus. In conclusion, PINK1-AS promotes Gαi1-driven GC progression by sponging miR-200a.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33958720     DOI: 10.1038/s41388-021-01812-7

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  47 in total

Review 1.  The emergence of long non-coding RNAs in the tumorigenesis of hepatocellular carcinoma.

Authors:  Xin Yang; Xia Xie; Yu-Feng Xiao; Rei Xie; Chang-Jiang Hu; Bo Tang; Bo-Sheng Li; Shi-Ming Yang
Journal:  Cancer Lett       Date:  2015-02-23       Impact factor: 8.679

2.  Gastrointestinal cancer: targeted therapies in gastric cancer-the dawn of a new era.

Authors:  Manish A Shah
Journal:  Nat Rev Clin Oncol       Date:  2013-12-03       Impact factor: 66.675

3.  microRNA-200a downregulation in human glioma leads to Gαi1 over-expression, Akt activation, and cell proliferation.

Authors:  Yuan-Yuan Liu; Min-Bin Chen; Long Cheng; Zhi-Qing Zhang; Zheng-Quan Yu; Qin Jiang; Gang Chen; Cong Cao
Journal:  Oncogene       Date:  2018-03-09       Impact factor: 9.867

4.  Antidepression action of BDNF requires and is mimicked by Gαi1/3 expression in the hippocampus.

Authors:  John Marshall; Xiao-Zhong Zhou; Gang Chen; Su-Qing Yang; Ya Li; Yin Wang; Zhi-Qing Zhang; Qin Jiang; Lutz Birnbaumer; Cong Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-05       Impact factor: 11.205

5.  Galpha(i1) and Galpha(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway.

Authors:  Cong Cao; Xuesong Huang; Yuyuan Han; Yinsheng Wan; Lutz Birnbaumer; Geng-Sheng Feng; John Marshall; Meisheng Jiang; Wen-Ming Chu
Journal:  Sci Signal       Date:  2009-04-28       Impact factor: 8.192

Review 6.  Gastric cancer-molecular and clinical dimensions.

Authors:  Roopma Wadhwa; Shumei Song; Ju-Seog Lee; Yixin Yao; Qingyi Wei; Jaffer A Ajani
Journal:  Nat Rev Clin Oncol       Date:  2013-09-24       Impact factor: 66.675

Review 7.  Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang
Journal:  World J Gastroenterol       Date:  2017-08-28       Impact factor: 5.742

Review 8.  Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells.

Authors:  Xiaoqi Huo; Shuanglin Han; Guang Wu; Olivier Latchoumanin; Gang Zhou; Lionel Hebbard; Jacob George; Liang Qiao
Journal:  Mol Cancer       Date:  2017-10-23       Impact factor: 27.401

9.  Gαi1 and Gαi3mediate VEGF-induced VEGFR2 endocytosis, signaling and angiogenesis.

Authors:  Jian Sun; Wei Huang; Shuo-Fei Yang; Xiao-Pei Zhang; Qing Yu; Zhi-Qing Zhang; Jin Yao; Ke-Ran Li; Qin Jiang; Cong Cao
Journal:  Theranostics       Date:  2018-09-09       Impact factor: 11.556

10.  LncBook: a curated knowledgebase of human long non-coding RNAs.

Authors:  Lina Ma; Jiabao Cao; Lin Liu; Qiang Du; Zhao Li; Dong Zou; Vladimir B Bajic; Zhang Zhang
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

View more
  8 in total

1.  Long noncoding RNA FAM225A promotes the malignant progression of gastric cancer through the miR-326/PADI2 axis.

Authors:  Xiang Ma; Gang Wang; Hao Fan; Zengliang Li; Wangwang Chen; Jian Xiao; Peidong Ni; Kanghui Liu; Kuan Shen; Yuanhang Wang; Zekuan Xu; Li Yang
Journal:  Cell Death Discov       Date:  2022-01-11

2.  Development of a Prognostic Model Based on the Identification of EMT-Related lncRNAs in Triple-Negative Breast Cancer.

Authors:  Jiani Guo; Xuesong Yi; Zhuqing Ji; Mengchu Yao; Yu Yang; Wei Song; Mingde Huang
Journal:  J Oncol       Date:  2021-11-27       Impact factor: 4.375

3.  Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma.

Authors:  Peipei Wang; Yueyun Chen; Yue Zheng; Yang Fu; Zhenyu Ding
Journal:  Dis Markers       Date:  2021-10-19       Impact factor: 3.434

4.  Interdependent Transcription of a Natural Sense/Antisense Transcripts Pair (SLC34A1/PFN3).

Authors:  Hany S Zinad; Chanachai Sae-Lee; Maria Ascensión Ariza-Mateos; Grace Adamson; Mushtaq Mufleh Khazeem; Amber Knox; Git Chung; Jelena Mann; Andreas Werner
Journal:  Noncoding RNA       Date:  2022-02-11

5.  Identification of Gαi3 as a promising target for osteosarcoma treatment.

Authors:  Zheng-Jun Bian; Hua-Jian Shan; Yun-Rong Zhu; Ce Shi; Min-Bin Chen; Yu-Min Huang; Xiao-Dong Wang; Xiao-Zhong Zhou; Cong Cao
Journal:  Int J Biol Sci       Date:  2022-01-24       Impact factor: 6.580

6.  Identification of Gαi3 as a novel molecular therapeutic target of cervical cancer.

Authors:  Jie Zhang; De-Pei Yin; Yan Zhang; Jia-Nan Zhang; Yan Yang; Zhi-Qing Zhang; Li Zhou; Yan Lv; Hai-Wei Huang; Cong Cao
Journal:  Int J Biol Sci       Date:  2022-09-06       Impact factor: 10.750

7.  A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma.

Authors:  Lianghua Luo; Leyan Li; Li Liu; Zongfeng Feng; Qingwen Zeng; Xufeng Shu; Yi Cao; Zhengrong Li
Journal:  Front Genet       Date:  2022-03-07       Impact factor: 4.599

8.  The ELF3-regulated lncRNA UBE2CP3 is over-stabilized by RNA-RNA interactions and drives gastric cancer metastasis via miR-138-5p/ITGA2 axis.

Authors:  Dandan Li; Jiajun She; Xinhui Hu; Meixin Zhang; Ruonan Sun; Shanshan Qin
Journal:  Oncogene       Date:  2021-07-17       Impact factor: 9.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.